Analystreport

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at Royal Bank of Canada from $65.00 to $58.00. They now have an "outperform" rating on the sto...

Corbus Pharmaceuticals Holdings, Inc.  (CRBP) 
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: corbuspharma.com